Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−7.54 M EUR
2.93 M EUR
About NeuroMetrix, Inc.
Sector
Industry
CEO
Daniel S. Goldberger
Website
Headquarters
Woburn
Founded
1996
ISIN
US6412558800
FIGI
BBG000FP0CB8
NeuroMetrix, Inc. engages in the development and manufacture of diagnostic and therapeutic neurostimulation-based medical devices. Its products include DPNCheck, Quell, and ADVANCE system. It also focuses on the sale of medical equipment and consumables. The company was founded by Shai N. Gozani in June 1996 and is headquartered in Woburn, MA.
Related stocks
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange NeuroMetrix, Inc. stocks are traded under the ticker NLZ0.
Yes, you can track NeuroMetrix, Inc. financials in yearly and quarterly reports right on TradingView.
NeuroMetrix, Inc. is going to release the next earnings report on Oct 20, 2025. Keep track of upcoming events with our Earnings Calendar.
No, NLZ0 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Oct 18, 2025, the company has 13 employees. See our rating of the largest employees — is NeuroMetrix, Inc. on this list?
Like other stocks, NLZ0 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NeuroMetrix, Inc. stock right from TradingView charts — choose your broker and connect to your account.